Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02218983
Other study ID # 620651
Secondary ID
Status Recruiting
Phase N/A
First received August 1, 2014
Last updated April 14, 2017
Start date June 2014
Est. completion date June 2018

Study information

Verified date April 2017
Source Riverside County Regional Medical Center
Contact Aron Depew, MD
Phone 951-486-5857
Email adepew@co.riverside.ca.us
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Primary caregiver thoracic ultrasound (U/S) is a skill which is growing in utility in critical care. First introduced for volume assessment in nephrology and cardiology, it is now being researched in emergency and critical care. Data is still evolving in its use in initial trauma evaluation. Inferior vena cava (IVC) diameter correlates with outcome in trauma, but utility of its measurement on U/S in the emergency department still has some controversy. In trauma specifically, small studies suggests benefit to the use of U/S to predict volume status, and most of these data are from one author. It is not known if this can be applied more broadly. The prognostic value of findings on limited transthoracic echocardiogram (LTTE, SonoSite Ultrasound) has been studied in several small studies, and only one small randomized controlled trial has proven benefit to its use. Due to inter-rater reliability and the fact that all reports on credentialing of thoracic ultrasound use in the trauma bay are from one group, it is not known if it can be applied to all trauma populations.

Research question:

Does LTTE (SonoSite Ultrasound) predict mortality, emergency surgery, intensive care unit (ICU) stay, hospital stay, time on ventilator, number of transfusions, or renal failure as well as or better than other methods of organ perfusion?

Hypotheses:

1. Use of LTTE is associated with improved outcomes (less organ failure, decreased hospital and ICU stays, transfusions, and mortality).

2. LTTE predicts mortality, emergency surgery, ICU stay, hospital stay, time on ventilator, number of and transfusions better than other methods of organ perfusion (tachycardia, hypotension, lactate, lactate clearance, creatinine, base deficit).


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date June 2018
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Patients arriving to trauma bay aged 18 or higher

- Hypotensive (systolic blood pressure (SBP) < 90 mmHg or mean arterial pressure (MAP) < 65, on 2 measurements)

- Respiratory failure (requiring mechanical ventilation)

Exclusion Criteria:

- Unable to draw blood before transfusion or fluid challenge

- Patient arrests within 10 minutes of arrival

- Pregnant

Note: If inferior vena cava (IVC) not visible on ultrasound (U/S), pt will go to non-IVC group.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Limited Transthoracic Echocardiogram (LTTE, SonoSite Ultrasound)

Other:
Usual care


Locations

Country Name City State
United States Riverside County Regional Medical Center Moreno Valley California

Sponsors (1)

Lead Sponsor Collaborator
Riverside County Regional Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary length of stay in the intensive care unit length of stay in the intensive care unit, not to exceed 30 days
Secondary mortality (death) mortality (death) during hospital stay, not to exceed 30 days